Scopio Labs Unveils AI-Powered Solution to Fully Automate Blood Morphology
Scopio Labs has unveiled its Complete Blood Morphology (CBM) analyzer, aiming to automate and standardize blood smear analysis at scale.
Category: Hematology Instrumentation
Hematology Instrumentation
Latest
Hematology Instrumentation
Latest
Ad Astra Diagnostics Files 510(k) for Hematology Analyzer System
Ad Astra Diagnostics submitted a 510(k) application to the FDA for its QScout RLD rapid-result hematology system.
Hematology Instrumentation
Latest
Companies Partner to Develop IVD Solutions
Diagnostics company Sebia has partnered with biosystems firm Metafora to develop a portfolio of in-vitro tests.
Research: PixCell’s HemoScreen Plays Key Role in Minimizing Disease Spread
Researchers concluded that PixCell’s HemoScreen, a miniature, easy-to-use, AI and machine vision-enabled hematology analyzer, can fill the gap in point-of-care diagnostics.
Read More
Sysmex America to Distribute FDA-Cleared CellaVision DC-1 for Low-Volume Hematology Labs
The CellaVision DC-1 automates and simplifies the process of performing blood cell differentials in low-volume labs.
Read More
FDA Clears AI-Powered Full Field PBS Application
The Scopio Labs solution enables digitization and analysis of full field peripheral blood smears with decision support system tailored to augment hematology diagnostics.
Read More
Study Demonstrates New Tool for Rapid Evaluation of Acute Leukemia Patients
PixCell’s HemoScreen may be used to monitor pathological blood samples, improving treatment process for hematological patients.
Read More
October 2019 Tech Guide: Hematology and Homeostasis Analyzers
The Tech Guide from the October 2019 issue of Clinical Lab Products features hematology analyzers from such companies as Advanced Instruments, Beckman Coulter, Diagnostica Stago, EKF Diagnostics, Siemens Healthineers, Sight Diagnostics, Streck, and Sysmex America.
Read More
October 2020 Tech Guide: Hematology Analyzers
The Tech Guide from the October 2020 issue of Clinical Lab Products features hematology analyzers from such companies as Advanced Instruments, Beckman Coulter, EliTechGroup, Siemens Healthineers, Sight Diagnostics, Streck, and System America.
Read More
Diagnostic Platform for Low Resource Settings Integrates Miniaturized Technologies with AI
The Gazelle Diagnostic platform is built around microchip electrophoresis technology that both identifies and quantifies many hemoglobin variants.
Read More
Nova Biomedical Adds PT/INR Test to Allegro Analyzer
The Allegro and its StatStrip-A companion meter now provide 18 tests to help physicians make therapeutic decisions and adjustments at the point of care.
Read More
Diatron Launches Aquila 5Dretics Hematology Analyzer
The instrument uses only two reagents, has low reagent consumption, requires only a small sample volume, and incorporates a continuous-loading autoloader that makes the analyzer a walkaway system convenient for all customers.
Read More
Hematology Analyzers Minimize Manual Microscopy Slide Reviews
Studies confirm strong performance for body fluid and pathological sample analysis using the automated Helo platform.
Read More
Beckman Coulter Updates Hematology Analyzer Recall
At FDA urging, Beckman Coulter has repeated its Class I recall letters for three hematology analyzers.
Read More
MedTest Dx Unveils Hematology Analyzer for High-Throughput Decentralized Testing
MedTest Dx’s BC-5390 automated 5-part differential hematology analyzer streamlines workflows in the hematology lab.
Read More
Beckman Coulter Files FDA 510(k) Submission for Early Sepsis Indicator
Offered as part of a routine CBC with differential test, the hematology-based solution alerts emergency department clinicians to the possibility of sepsis earlier than any other indicator.
Read More
Beckman Coulter Launches DxH 900 Hematology Analyzer
Many of the parameters measured by the analyzer address critical health conditions, such as anemia, leukopenia, and thrombocytopenia.
Read MoreStudy Shows Horiba POC Analyzer Quickens Clinical Decisionmaking
The study found that using POC tests as a replacement for laboratory tests resulted in earlier decisionmaking in approximately 75% of cases across three UK hospital sites.
Read More